CA1097657A - 5-(substituted phenyl)-oxazolidinones and sulphur analogues thereof and also a process for their production - Google Patents
5-(substituted phenyl)-oxazolidinones and sulphur analogues thereof and also a process for their productionInfo
- Publication number
- CA1097657A CA1097657A CA292,273A CA292273A CA1097657A CA 1097657 A CA1097657 A CA 1097657A CA 292273 A CA292273 A CA 292273A CA 1097657 A CA1097657 A CA 1097657A
- Authority
- CA
- Canada
- Prior art keywords
- oxazolidinone
- dimethoxyphenyl
- carbon atoms
- produced
- methoxyphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/16—Sulfur atoms
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19762655369 DE2655369A1 (de) | 1976-12-03 | 1976-12-03 | 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung |
DEP2655369.5 | 1976-12-03 | ||
DEP2745320.9 | 1977-10-05 | ||
DE19772745320 DE2745320A1 (de) | 1977-10-05 | 1977-10-05 | 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung ii |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1097657A true CA1097657A (en) | 1981-03-17 |
Family
ID=25771221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA292,273A Expired CA1097657A (en) | 1976-12-03 | 1977-12-02 | 5-(substituted phenyl)-oxazolidinones and sulphur analogues thereof and also a process for their production |
Country Status (19)
Country | Link |
---|---|
JP (1) | JPS5382777A (ru) |
AT (1) | AT357529B (ru) |
AU (1) | AU519994B2 (ru) |
CA (1) | CA1097657A (ru) |
CH (1) | CH635578A5 (ru) |
CS (1) | CS199694B2 (ru) |
DD (1) | DD133667A5 (ru) |
DK (1) | DK149850C (ru) |
FR (1) | FR2372814A1 (ru) |
GB (1) | GB1588639A (ru) |
GR (1) | GR64964B (ru) |
HU (1) | HU175676B (ru) |
IE (1) | IE46435B1 (ru) |
IL (1) | IL53520A (ru) |
IT (1) | IT1089341B (ru) |
LU (1) | LU78616A1 (ru) |
NL (1) | NL7713153A (ru) |
SE (1) | SE441446B (ru) |
SU (1) | SU888821A3 (ru) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2701215C2 (de) * | 1977-01-13 | 1982-10-14 | Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von Thiazolin-2-thionen |
US4348393A (en) * | 1978-06-09 | 1982-09-07 | Delalande S.A. | N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones |
DE3438839A1 (de) * | 1984-10-19 | 1986-04-24 | Schering AG, 1000 Berlin und 4709 Bergkamen | Pharmazeutische praeparate |
HU215433B (hu) * | 1986-04-29 | 2000-05-28 | Pfizer Inc. | Eljárás új 2-oxo-5-fenil-pirimidin-származékok előállítására |
US5459145A (en) * | 1988-01-19 | 1995-10-17 | Pfizer Inc. | Calcium independent camp phosphodiesterase inhibitor antidepressant |
JPH01135098U (ru) * | 1988-03-11 | 1989-09-14 | ||
WO1991007177A1 (en) * | 1989-11-13 | 1991-05-30 | Pfizer Inc. | Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders |
US5461056A (en) * | 1992-05-08 | 1995-10-24 | Pfizer Inc. | Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders |
GB9212673D0 (en) * | 1992-06-15 | 1992-07-29 | Celltech Ltd | Chemical compounds |
GB9222253D0 (en) * | 1992-10-23 | 1992-12-09 | Celltech Ltd | Chemical compounds |
GB9226830D0 (en) * | 1992-12-23 | 1993-02-17 | Celltech Ltd | Chemical compounds |
US5622977A (en) * | 1992-12-23 | 1997-04-22 | Celltech Therapeutics Limited | Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same |
GB9304920D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
GB9304919D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
EP0738268B1 (en) * | 1993-12-22 | 2004-03-03 | Celltech R&D Limited | Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors |
GB9326173D0 (en) * | 1993-12-22 | 1994-02-23 | Celltech Ltd | Chemical compounds and process |
US6245774B1 (en) | 1994-06-21 | 2001-06-12 | Celltech Therapeutics Limited | Tri-substituted phenyl or pyridine derivatives |
US5786354A (en) * | 1994-06-21 | 1998-07-28 | Celltech Therapeutics, Limited | Tri-substituted phenyl derivatives and processes for their preparation |
GB9412573D0 (en) * | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
GB9412571D0 (en) * | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
GB9412672D0 (en) * | 1994-06-23 | 1994-08-10 | Celltech Ltd | Chemical compounds |
GB9523675D0 (en) | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
GB9526245D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
GB9526246D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
GB9608435D0 (en) * | 1996-04-24 | 1996-06-26 | Celltech Therapeutics Ltd | Chemical compounds |
GB9619284D0 (en) * | 1996-09-16 | 1996-10-30 | Celltech Therapeutics Ltd | Chemical compounds |
GB9622363D0 (en) * | 1996-10-28 | 1997-01-08 | Celltech Therapeutics Ltd | Chemical compounds |
GB9625184D0 (en) * | 1996-12-04 | 1997-01-22 | Celltech Therapeutics Ltd | Chemical compounds |
US6057329A (en) * | 1996-12-23 | 2000-05-02 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives |
GB9705361D0 (en) | 1997-03-14 | 1997-04-30 | Celltech Therapeutics Ltd | Chemical compounds |
GB9713087D0 (en) * | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
GB9914258D0 (en) | 1999-06-18 | 1999-08-18 | Celltech Therapeutics Ltd | Chemical compounds |
GB9924862D0 (en) | 1999-10-20 | 1999-12-22 | Celltech Therapeutics Ltd | Chemical compounds |
-
1977
- 1977-11-28 SU SU772546252A patent/SU888821A3/ru active
- 1977-11-29 NL NL7713153A patent/NL7713153A/xx not_active Application Discontinuation
- 1977-12-01 IT IT30254/77A patent/IT1089341B/it active
- 1977-12-01 LU LU78616A patent/LU78616A1/xx unknown
- 1977-12-01 DD DD7700202354A patent/DD133667A5/xx unknown
- 1977-12-01 SE SE7713635A patent/SE441446B/xx not_active IP Right Cessation
- 1977-12-02 IE IE2446/77A patent/IE46435B1/en not_active IP Right Cessation
- 1977-12-02 GR GR54913A patent/GR64964B/el unknown
- 1977-12-02 JP JP14492277A patent/JPS5382777A/ja active Granted
- 1977-12-02 CH CH1477977A patent/CH635578A5/de not_active IP Right Cessation
- 1977-12-02 AU AU31175/77A patent/AU519994B2/en not_active Expired
- 1977-12-02 IL IL53520A patent/IL53520A/xx unknown
- 1977-12-02 HU HU77SCHE632A patent/HU175676B/hu not_active IP Right Cessation
- 1977-12-02 GB GB50350/77A patent/GB1588639A/en not_active Expired
- 1977-12-02 DK DK536677A patent/DK149850C/da not_active IP Right Cessation
- 1977-12-02 CA CA292,273A patent/CA1097657A/en not_active Expired
- 1977-12-05 AT AT868677A patent/AT357529B/de not_active IP Right Cessation
- 1977-12-05 FR FR7736525A patent/FR2372814A1/fr active Granted
- 1977-12-05 CS CS778086A patent/CS199694B2/cs unknown
Also Published As
Publication number | Publication date |
---|---|
LU78616A1 (ru) | 1978-04-20 |
IT1089341B (it) | 1985-06-18 |
AU3117577A (en) | 1979-06-07 |
DK149850B (da) | 1986-10-13 |
HU175676B (hu) | 1980-09-28 |
NL7713153A (nl) | 1978-06-06 |
FR2372814B1 (ru) | 1980-10-10 |
SE7713635L (sv) | 1978-06-04 |
IL53520A (en) | 1981-07-31 |
GB1588639A (en) | 1981-04-29 |
ATA868677A (de) | 1979-12-15 |
SE441446B (sv) | 1985-10-07 |
IE772446L (en) | 1978-06-03 |
IL53520A0 (en) | 1978-03-10 |
GR64964B (en) | 1980-06-10 |
SU888821A3 (ru) | 1981-12-07 |
IE46435B1 (en) | 1983-06-15 |
JPS5382777A (en) | 1978-07-21 |
DK149850C (da) | 1987-04-27 |
CH635578A5 (en) | 1983-04-15 |
DD133667A5 (de) | 1979-01-17 |
CS199694B2 (en) | 1980-07-31 |
DK536677A (da) | 1978-06-04 |
AT357529B (de) | 1980-07-10 |
AU519994B2 (en) | 1982-01-07 |
FR2372814A1 (fr) | 1978-06-30 |
JPS6154792B2 (ru) | 1986-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1097657A (en) | 5-(substituted phenyl)-oxazolidinones and sulphur analogues thereof and also a process for their production | |
US4186129A (en) | 5-(Substituted phenyl)-oxazolidinones and their sulfur analogs | |
CA1077496A (en) | 4-(polyalkoxy-phenyl)-2-pyrrolidone ii | |
KR20020087379A (ko) | 신규 α-아미노산 화합물, 이의 제조 방법 및 이를함유하는 약제학적 조성물 | |
EP0005689B1 (fr) | Nouveaux acides lactame-N-acétiques et leurs amides, leurs procédés de préparation et compositions thérapeutiques | |
US8288433B2 (en) | Diazeniumdiolate compounds, a process for their preparation and pharmaceutical compositions containing them | |
FR2744448A1 (fr) | Nouvelles piperidines derivees d'aryl piperazine, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments | |
US4267345A (en) | Aryltrifluoroethylamines | |
IL43749A (en) | Cyclopropylmethylamine derivatives of n-containing heterocyclic compounds their production and pharmaceutical compositions containing them | |
KR940010179B1 (ko) | 니트로 에텐 유도체의 제조방법 | |
CA1117944A (fr) | Procedes de preparation de nouvelles piperazines disubstituees | |
EP0009362B1 (en) | Heterocyclic derivatives of guanidine, their preparation and pharmaceutical formulations comprising them | |
JPS6058747B2 (ja) | アミノ化合物の製法 | |
US6570021B2 (en) | Intermediates for the preparation of 2-imidazolin-5-ones | |
EP0101380A2 (fr) | Nicotinamide 1-oxyde N-substitué, ses sels, procédé pour leur préparation et compositions pharmaceutiques en contenant | |
EA000535B1 (ru) | Новые противосудорожные i-ar(алк)ил-имидазолин-2-оны, содержащие в 4-положении двузамещенный остаток амина, и способ их получения | |
CA1100968A (fr) | Procedes de preparation de nouvelles piperazines disubstituees | |
CH632999A5 (fr) | (2-thio)urees 1,3-disubstituees. | |
CA2128560A1 (fr) | Piperazines substituees, leur procede de preparation et les compositions pharmaceutiques les contenant | |
FR2482595A1 (fr) | Procede de preparation de n-(2-(((5-(dial-kylamino) - methyl-2-furanyl)-methyl)-thio)-ethyl)-n'-alkyl-2-nitro-1,1-ethenediamines et des intermediaires de synthese mis en oeuvre dans ce procede | |
EP0820440B1 (en) | Novel carbamate compounds having n-substituted thiocarbamoyl group and process for preparing the same | |
Kawashima et al. | Hydrogenolysis of the C O bond of the 1, 2, 4‐oxadiazine ring. Adams platinum hydrogenation of 3‐aryl‐5, 6‐dihydro‐5‐(substituted)‐methylene‐4H‐1, 2, 4‐oxadiazine derivatives | |
Lora-Tamayo et al. | Thiocyanates in heterocyclic synthesis through nitrilium salts | |
FR2625503A1 (fr) | Derives de dioxazocine, leur procede de preparation et compositions pharmaceutiques les contenant | |
CA2251637C (fr) | Nouveaux [2-(1-piperazinyl)ethoxy]methyle substitues |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |